Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

APTX

Aptinyx (APTX)

Aptinyx Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:APTX
日付受信時刻ニュースソース見出しコード企業名
2023/12/2200 : 52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTXAptinyx Inc
2023/06/2803 : 14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
2023/05/2505 : 50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
2023/05/2505 : 44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
2023/05/2505 : 44Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:APTXAptinyx Inc
2023/05/2505 : 40Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
2023/05/2505 : 40Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
2023/05/2321 : 26Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:APTXAptinyx Inc
2023/05/1605 : 46Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:APTXAptinyx Inc
2023/05/1121 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
2023/05/0521 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
2023/04/2905 : 19Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:APTXAptinyx Inc
2023/04/2522 : 24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
2023/03/3105 : 31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APTXAptinyx Inc
2023/03/3105 : 05Business WireAptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic AlternativesNASDAQ:APTXAptinyx Inc
2023/03/1705 : 20Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
2023/03/0122 : 32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
2023/02/2806 : 03Business WireAptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies and Provides Pipeline and Corporate UpdateNASDAQ:APTXAptinyx Inc
2023/02/1506 : 49Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
2023/01/3121 : 47Business WireAptinyx to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:APTXAptinyx Inc
2023/01/0606 : 18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APTXAptinyx Inc
2023/01/0606 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APTXAptinyx Inc
2022/12/1220 : 25TipRanksH.C. Wainwright Keeps Their Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
2022/12/0906 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
2022/12/0206 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
2022/11/1021 : 45Business WirePreclinical Data from Aptinyx’s NMDA Receptor Modulators to be Presented at the 52nd Annual Meeting of the Society for NeuroscienceNASDAQ:APTXAptinyx Inc
2022/11/1013 : 26TipRanksSVB Securities Keeps Their Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
2022/11/1000 : 16TipRanksBMO Capital Remains a Buy on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
2022/11/0906 : 32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APTXAptinyx Inc
2022/11/0906 : 17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
 Showing the most relevant articles for your search:NASDAQ:APTX